Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

3 Companies Getting Whacked by the Global Semiconductor ShortagePhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
3 Companies Getting Whacked by the Global Semiconductor Shortage

The global semiconductor shortage came about due to challenges manufacturing new chips, pandemic-related disruptions, the secular growth of new technologies, and elevated demand for consumer

Here's How Much You Could Be Making From Johnson & Johnson's Dividend 5 Years From Now
Here's How Much You Could Be Making From Johnson & Johnson's Dividend 5 Years From Now

If you only look at a stock's current dividend yield, you could get an incomplete picture as to how much recurring revenue it can actually generate for you. Dividend growth is an important

Could Jushi Holdings Be a Millionaire-Maker Stock?
Could Jushi Holdings Be a Millionaire-Maker Stock?

Making a million dollars from cannabis doesn't seem like an impossible feat given the industry's growth potential. By 2026, cannabis research company BDSA projects that the industry will be worth

Why Logitech International Is One of the Best Growth Stocks to Buy Right Now
Why Logitech International Is One of the Best Growth Stocks to Buy Right Now

Logitech International (NASDAQ: LOGI) is a classic example of a growth stock trading at a reasonable price, especially after its latest earnings report, which shows us that it can keep growing in a

3 Signs It's Time to Ditch Your 401(k)
3 Signs It's Time to Ditch Your 401(k)

As someone who writes about retirement planning a lot, I'm often asked whether it pays to take advantage of a 401(k) plan if there's one available. And generally, my answer is a resounding "yes."

Canopy Growth Stock Is Down More Than 50% From Its 52-Week High: Is Now the Time to Buy?
Canopy Growth Stock Is Down More Than 50% From Its 52-Week High: Is Now the Time to Buy?

Canopy Growth (NASDAQ: CGC) released its fiscal 2020 third-quarter earnings report on Feb. 9. Its strong results for the period, which ended Dec. 31, helped drive its share price to a 52-week high

Dow Hits $35,000, Crushing the Nasdaq. What Does That Mean for Retirees?Photo, wide shot, wide-angle lens,  Diversified industrial company, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/3bc2ecaa-ddda-4d9f-865e-4df253bbd22f.png
Dow Hits $35,000, Crushing the Nasdaq. What Does That Mean for Retirees?

On Monday, the Dow Jones Industrial Average (DJIA) hit an intraday high above the $35,000 mark for the first time in history.

America's oldest stock index has produced a total return just shy of 17%

Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?Photo, wide shot, wide-angle lens,  Specialty food store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/7a8f69d5-c26e-46d9-b403-d3e5e9562eca.png
Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?

Pfizer (NYSE: PFE) just scored another first. The U.S. Food and Drug Administration (FDA) granted it authorization for the use of its coronavirus vaccine in a new age group -- 12 through 15. In

Is Sanofi a Good Buy in 2021?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Is Sanofi a Good Buy in 2021?

The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the

How Visa Direct Is Modernizing Money
How Visa Direct Is Modernizing Money

The flow of money is central to modern life. Banks and payments companies play extremely important roles in everything from receiving a paycheck to shopping online. This has never been more true

2 Best Biotech Stocks to Buy NowPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
2 Best Biotech Stocks to Buy Now

Biotech stocks are popular with investors because of their drugs' life-saving benefits and strong intellectual property moats. Current patent laws allow drug developers market exclusivity for two

3 Healthcare Stocks That Might Soar if Biden Gets This Part of His Budget ApprovedPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
3 Healthcare Stocks That Might Soar if Biden Gets This Part of His Budget Approved

One of the most notable items in Joe Biden's recent budget proposal is $6.5 billion to create an agency called the Advanced Research Projects Agency for Health, or ARPA-H. The naming is intended to

Is Trulieve Cannabis a Good Buy Ahead of Earnings?
Is Trulieve Cannabis a Good Buy Ahead of Earnings?

The pandemic-induced marijuana boom helped the U.S. cannabis industry sparkle. Florida-based Trulieve Cannabis (OTC: TCNNF), in particular, impressed investors with its outstanding performance last

This Growing Pot Stock Could Make You Rich in 5 YearsPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
This Growing Pot Stock Could Make You Rich in 5 Years

The U.S. cannabis market is still trying navigate its way through what I call the "three Rs of legalization": regulations, real estate, and reality. More and more states are legalizing medical and

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows

Buying a quality growth stock on a dip can be a great way to position yourself for some excellent profits. While it may be difficult to invest in something that is falling in value, if a business

These 2 REITs Are Safer Investments Than Their Average Customer: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
These 2 REITs Are Safer Investments Than Their Average Customer

Like most investors, I'm a big fan of gold rushes in new or rapidly expanding industries because that's where there's the most money to be made. When it comes to picking the right stock to benefit

3 Popular Stocks Expected to Lose 53% to 79%, According to Wall Street
3 Popular Stocks Expected to Lose 53% to 79%, According to Wall Street

For more than a year, the stock market has been on a historic run. Even though all stock market crashes and corrections are eventually erased by a bull-market rally, gains of as much as 88% in the

Is Vaxart a Buy?
Is Vaxart a Buy?

In the early days of the pandemic, Vaxart (NASDAQ: VXRT) mesmerized investors after beginning development of a tablet-based, room-temperature-stable coronavirus vaccine. The stock subsequently

Surprise! Sundial Growers Delivers Positive Adjusted EBITDA in Q1
Surprise! Sundial Growers Delivers Positive Adjusted EBITDA in Q1

Sundial Growers (NASDAQ: SNDL) came out of nowhere to become one of the hottest pot stocks on the market this year. However, the Canadian cannabis producer has given up much of its earlier gains

2 Reasons to Invest in Cryptocurrency -- and 3 Reasons Not to:
2 Reasons to Invest in Cryptocurrency -- and 3 Reasons Not to

Cryptocurrency has been having quite the year. Digital currencies are the latest phenomenon in the investing world, and several different types of currencies have been shattering records.

Bitcoin

Here Are the 3 Most Important Numbers in Moderna's Earnings ReportPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Here Are the 3 Most Important Numbers in Moderna's Earnings Report

Moderna's (NASDAQ: MRNA) transformation from a clinical-stage biotech company to a commercial-stage one has been rapid -- and impressive. Only a year ago, Moderna didn't even have products on the

Why Novavax Could Beat Moderna in Europe After Pfizer's Huge EU Vaccine Deal: https://investors.biontech.de/media-materials
Why Novavax Could Beat Moderna in Europe After Pfizer's Huge EU Vaccine Deal

The name of the game with COVID-19 vaccines right now is supply deals. Companies with big supply agreements are in a position to make a lot of money.

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX)

The Best Warren Buffett Stocks to Buy With $300 Right Now
The Best Warren Buffett Stocks to Buy With $300 Right Now

Suppose one of the world's greatest investors told you some of his favorite stock picks. However, there was a problem: You only had $300 to invest, and many of his stocks were too expensive for you

3 Stocks That Could Be Worth More Than Apple by 2035
3 Stocks That Could Be Worth More Than Apple by 2035

The stock market is a wealth-building machine for patient investors. However, it's also dynamic.

Back in 1999, the 10 largest publicly traded companies by market cap included the likes of Lucent

46% of Americans Believe This Myth That Could Needlessly Delay Social Security
46% of Americans Believe This Myth That Could Needlessly Delay Social Security

Most retirees work their whole lives to become entitled to receive Social Security benefits. These retirement benefits can help cover costs in your later years once you're no longer earning a